EMILY MCINTOSH: Open Payments
NPI 1861901621 · DESOTO, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$765 in 42 payments from 17 companies in 2025. Trend: 2023 $634 · 2024 $771 · 2025 $765
Food & beverage: $765
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $114 |
| PFIZER INC. | 4 | $80 |
| Astellas Pharma US Inc | 4 | $73 |
| ABBVIE INC. | 4 | $63 |
| Otsuka America Pharmaceutical, Inc. | 3 | $56 |
| Amgen Inc. | 1 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $46 |
| Insulet Corporation | 1 | $45 |
| Phathom Pharmaceuticals, Inc. | 4 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
Products named: JARDIANCE, Veozah, REXULTI, KRYSTEXXA, Kerendia, OMNIPOD, VOQUEZNA, NURTEC ODT.
Industry payments across IA — which companies pay providers there.
